Search Results

• • 2,769 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Arthritis drug approved

  From:British Medical Journal (Vol. 324, Issue 7340) Peer-Reviewed

  Mar. 30, 200226 words Brief article The National Institute for Clinical Excellence has recommended the use of etanercept for the treatment of juvenile idiopathic arthritis and etanercept and infliximab for rheumatoid arthritis....

• Body image and self-esteem in patients with rheumatoid arthritis/Romatoid artrit'li hastalarda beden imaji ve benlik saygisi

  Authors:Emine Kurt, Kursat Ozdilli, and Hatice YorulmazFrom:Archives of Neuropsychiatry (Vol. 50, Issue 3) Peer-Reviewed

  Sept. 20133,599 words Report 1450LABSTRACT Introduction: The study was conducted in order to investigate the effect of disease-related variables, such as socio-demographic characteristics, disease complaints, and necrosis factor (anti-TNF) use, on...

• Rheumatoid factor positivity is associated with increased joint destruction and upregulation of matrix metalloproteinase 9 and cathepsin K gene expression in the peripheral blood in rheumatoid arthritic patients treated with methotrexate

  Authors:Elena V. Tchetina, Natalia V. Demidova, Dmitry E. Karateev, and Eugeny L. NasonovFrom:International Journal of RheumatologyPeer-Reviewed

  Annual 20136,693 words Report 1490LWe evaluated changes in gene expression of mTOR, p21, caspase-3, ULK1, TNF[alpha], matrixmetalloproteinase (MMP)-9, and cathepsin K in the whole blood of rheumatoid arthritic (RA) patients treated with methotrexate...

• Prevalence of silent nontraumatic vertebral fracture in rheumatoid arthritis: relation with disease duration, disease activity, corticosteroid, and hip buckling ratio

  Authors:Mohamed El-Wakd, Omar Omar, and Hala SennaFrom:Egyptian Rheumatology and Rehabilitation (Vol. 41, Issue 3) Peer-Reviewed

  July-September 20143,548 words Report 1390LByline: Mohamed. El-Wakd, Omar. Omar, Hala. Senna Objectives To detect the prevalence of silent nontraumatic vertebral fractures (VFs) in patients with rheumatoid arthritis (RA) and its relation with disease...

• The -174G/C and -572G/C interleukin 6 promoter gene polymorphisms in Mexican patients with rheumatoid arthritis: a case-control study

  Authors:S.A. Zavaleta-Muniz, B.T. Martin-Marquez, L. Gonzalez-Lopez, N.G. Gonzalez-Montoya, M.L. Diaz-Toscano, J.M. Ponce- Guarneros, et al.From:Journal of Immunology Research (Vol. 2013) Peer-Reviewed

  Annual 20132,901 words Report 1330LObjective. There is a lack of information about the genotype frequencies of IL-6 -174G/C and -572G/C polymorphisms in Mexicans with rheumatoid arthritis (RA). Therefore, the aim of this study was to evaluate the...

• A rare case of temporal arteritis with rheumatoid arthritis and interstitial lung disease mimicking pulpo-periodontal pathology

  Authors:Sanjay Vasudevan, Ajay Palle, Dulapalli Sylvia, Valli Renuka, and Radhika ChallaFrom:Journal of Indian Society of Periodontology (Vol. 18, Issue 4) Peer-Reviewed

  July-August 20142,962 words Case study 1740LByline: Sanjay. Vasudevan, Ajay. Palle, Dulapalli. Sylvia, Valli. Renuka, Radhika. Challa A 75-year-old male patient was planned for dental treatment due to pain of suspected pulpo-periodontal origin in relation to...

• FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis

  Authors:Cristina Lucia Davila-Fajardo, Tahar van der Straaten, Rene Baak-Pablo, Catalina Medarde Caballero, Jose Cabeza Barrera, Tom W Huizinga, et al.From:Pharmacogenomics (Vol. 16, Issue 4) Peer-Reviewed

  Mar. 20155,148 words Report 1630LAuthor(s): Cristina Lucía Dávila-Fajardo aff1 aff2 , Tahar van der Straaten aff2 , Rene Baak-Pablo aff2 , Catalina Medarde Caballero aff1 , Jose Cabeza Barrera aff1 , Tom W Huizinga aff3 , Henk-Jan Guchelaar [*] aff2 ,...

• Spectrum of Neuro-Sjogren's syndrome in a tertiary care center in south India

  Authors:Ravi Yadav, Pramod Krishnan, Girish Kulkarni, T. Yasha, M. Kumar, and D. NagrajaFrom:Annals of Indian Academy of Neurology (Vol. 14, Issue 2) Peer-Reviewed

  April-June 20113,452 words Report 1720LByline: Ravi. Yadav, Pramod. Krishnan, Girish. Kulkarni, T. Yasha, M. Kumar, D. Nagraja Background: Neurological affection in Sjogren's syndrome (SS) can occur in the central and peripheral nervous system. Literature...

• Statins reduce cardiovascular events in OA and RA

  From:The Journal of Musculoskeletal Medicine (Vol. 29, Issue 2) Peer-Reviewed

  Mar. 2012239 words Brief article 1320LStatins help reduce total cholesterol (TC) concentrations in patients with osteoarthritis (OA) or rheumatoid arthritis (RA). The use of statins is associated with reduced cardiovascular (CV) events and mortality in...

• The new ASAS classification criteria for axial and peripheral spondyloarthritis: promises and pitfalls

  Authors:Sarah Lipton and Atul DeodharFrom:International Journal of Clinical Rheumatology (Vol. 7, Issue 6) Peer-Reviewed

  Dec. 20125,017 words Article 1470LAuthor(s): Sarah Lipton 1 , Atul Deodhar [*] 2 KEYWORDS : ankylosing spondylitis; axial spondyloarthritis; dactylitis; enthesitis; HLA-B27; inflammatory bowel disease-related arthrits; psoriatic arthritis;...

• Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients

  Authors:Petra Bohanec Grabar, Luis J Leandro-Garcia, Lucia Inglada-Perez, Cristina Rodriguez-Antona, and Vita DolzanFrom:Pharmacogenomics (Vol. 13, Issue 14) Peer-Reviewed

  Nov. 20126,692 words Report 1430LAuthor(s): Petra Bohanec Grabar 1 , Luis J Leandro-García 2 , Lucía Inglada-Pérez 2 3 , Dušan Logar 4 , Cristina Rodríguez-Antona 2 3 , Vita Dolzan [*] 5 KEYWORDS : methotrexate; polymorphism; reduced...

• Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritis

  Authors:Catherine O'Doherty, Matthew Schnabl, Llewellyn Spargo, Leslie G Cleland, Michael James, Susanna M Proudman, et al.From:Pharmacogenomics (Vol. 13, Issue 2) Peer-Reviewed

  Sept. 20124,437 words Report 1400LAuthor(s): Catherine O'Doherty 1 , Matthew Schnabl 1 , Llewellyn Spargo 2 , Leslie G Cleland 2 3 , Michael James 2 3 , Susanna M Proudman 2 3 , Michael D Wiese [*] 4 KEYWORDS : DHODH; leflunomide;...

• Living life without B cells: is repeated B-cell depletion a safe and effective long-term treatment plan for rheumatoid arthritis?

  Authors:David R Chen and Philip L CohenFrom:International Journal of Clinical Rheumatology (Vol. 7, Issue 2) Peer-Reviewed

  Apr. 20125,537 words Article 1400LAuthor(s): David R Chen 1 , Philip L Cohen [**] 2 KEYWORDS : adverse effects; anti-CD20; B cells; rheumatoid arthritis; rituximab; treatment efficacy The efficacy of B-cell depletion therapy using anti-CD20...

• Infliximab: skin and pulmonary sarcoidosis: case report

  From:Reactions Weekly (Issue 1287)

  Feb. 6, 2010229 words Brief article, Case ... [S] A 55-year-old woman with seronegative rheumatoid arthritis developed skin and pulmonary sarcoidosis while receiving infliximab [frequency of administration not stated]. The woman received her first infliximab...

• Etanercept: melanoma in an elderly patient?: case report

  From:Reactions Weekly (Issue 1309)

  July 10, 2010157 words Brief article, Case ... 890L[S] An 84-year-old woman, with a history of basal cell carcinomas and dysplastic nevus excision, commenced etanercept 25mg twice weekly for rheumatoid arthritis in 2003. She presented with an asymmetrical...

• Adalimumab: pulmonary tuberculosis: case report

  From:Reactions Weekly (Issue 1330)

  Dec. 4, 2010345 words Brief article, Case ... 1030L[S] A 41-year-old woman, who had a negative pretreatment screening skin-test for tuberculosis, developed pulmonary tuberculosis during treatment with adalimumab for rheumatoid arthritis. The woman was receiving...

• The AMBITION trial: tocilizumab monotherapy for rheumatoid arthritis

  Author:Graeme JonesFrom:Expert Review of Clinical Immunology (Vol. 6, Issue 2) Peer-Reviewed

  Mar. 20103,375 words Article 1340LAuthor(s): Graeme Jones 1 Keywords : IL-6; rheumatoid; tocilizumab; trial Rheumatoid arthritis (RA) is the most common type of inflammatory arthritis. There have been a number of nonbiologic disease...

• The older rheumatoid arthritis patients: who are they and how should they be treated?

  Authors:Veena K Ranganath, Sogol Amjadi, Edmond Melikterminas, and Daniel E FurstFrom:Aging Health (Vol. 6, Issue 5) Peer-Reviewed

  Oct. 201012,884 words Article 1280LAuthor(s): Veena K Ranganath 1 , Sogol Amjadi 1 , Edmond Melikterminas 1 , Daniel E Furst [[dagger]] 2 Keywords: Keywords * aging; biologics; comorbidities; DMARDs; older onset rheumatoid arthritis; rheumatoid...

• Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus

  Authors:Sofia de Achaval and Maria E Suarez-AlmazorFrom:International Journal of Clinical Rheumatology (Vol. 5, Issue 3) Peer-Reviewed

  June 20108,498 words Report Author(s): Sofia de Achaval 1 , Maria E Suarez-Almazor [[dagger]] 2 KEYWORDS: adherence; disease-modifying antirheumatic drugs; rheumatoid arthritis; systematic review; systemic lupus erythematosus Treatment...

• IL-6 is a critical cytokine for inflammatory bone loss in rheumatoid arthritis

  Authors:Benoit Le Goff, Evange Romas, and Nicole C WalshFrom:International Journal of Clinical Rheumatology (Vol. 5, Issue 6) Peer-Reviewed

  Dec. 20102,435 words Editorial 1340LAuthor(s): Benoit Le Goff [[dagger]] 1 , Evange Romas 2 , Nicole C Walsh 3 KEYWORDS: bone erosions; IL-6; osteoblasts; osteoclasts; rheumatoid arthritis Among the cytokines implicated in inflammatory bone loss,...